Collection and analysis of prostate cancer biospecimens
Official title: Biospecimen Core
Funded at Dana-Farber Cancer Inst · NIH-10916211 · Data updated 2026-11-12
This study is looking for prostate cancer patients to share blood and tissue samples, which will help researchers better understand the disease and improve treatments, so your participation can make a real difference in patient care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $182,166 |
| NIH project number | 5P50CA272390-02 |
| Project ID | NIH-10916211 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are prostate cancer patients who are willing to provide blood and tissue samples for research purposes.
✕Less likely to help
Patients who do not have prostate cancer or are not willing to participate in biospecimen collection may not benefit from this research.
What this research studies
This research focuses on acquiring and characterizing biospecimens, such as blood and tissue samples, from prostate cancer patients to support translational research. By maintaining a biorepository linked with clinical data, the project aims to develop preclinical models that are relevant to patient care. The research involves collaboration with investigators to provide pathology services and advanced molecular assays, enhancing the understanding of prostate cancer and its treatment. Patients who consent to participate will contribute to a database that aids in the evaluation of treatment responses and disease progression.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for prostate cancer patients.
How similar studies have gone: Previous research has shown success in utilizing biospecimen banks to advance cancer treatment and understanding, indicating that this approach is both established and effective.
Where this research is happening
-
Dana-Farber Cancer Inst
Boston, United States Active
Researchers
- Principal investigator: Pomerantz, Mark M. — Dana-Farber Cancer Inst
- Study coordinator: Pomerantz, Mark M.
Related research
Other NIH-funded projects on the same topics.
-
Helping young people with cancer understand their genetic risks
This study is creating a special program to help teenagers and young adults with hereditary cancer risks learn about their health and make smart choices, while also supporting their families along the way.
-
Core administrative hub for a multifaceted cancer center program
A large, international cancer research program at Dana-Farber aims to advance a curative strategy for multiple myeloma by coordinating translational research, clinical trials, and data analysis.
-
Automated, interactive lab tool to define radiation targets in cancer care
Aims to make it easier and safer to outline the area to treat in radiation therapy for cancers by using smart software and a patient-friendly interface.
-
Cancer Atlas Network data hub to share big cancer data
A national project helps researchers store, harmonize, and share large cancer data collections so doctors and scientists can learn from many patients.
-
Bridge-building cancer research partnership for education, outreach, and science
A joint effort between UMass Boston and Harvard Cancer Consortium to accelerate cancer research and education by connecting lower-resourced institutions with a leading cancer center.
-
NexTGen: Next-Generation T cell therapy for childhood cancers
A charity-friendly overview: researchers at Dana-Farber are developing advanced engineered T-cell therapies to treat pediatric solid cancers like brain tumors and sarcomas.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.